Sponsor
CSL Behring
Clinical research sponsor
Clinical trials
16 shownA Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)NCT07619820 · lead sponsor · 2026-06-17
RECRUITINGCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)NCT05485961 · lead sponsor · 2024-04-27
RECRUITINGVascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney DiseaseNCT04419467 · lead sponsor · 2020-09-14
COMPLETEDA Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Patients With Mild-to-moderate Asthma and in Healthy VolunteersNCT04082754 · lead sponsor · 2019-11-28
COMPLETEDStudy to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · lead sponsor · 2018-03-21
COMPLETEDPhase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid ArthritisNCT02015520 · lead sponsor · 2012-06-01
COMPLETEDPhase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to MethotrexateNCT01373151 · lead sponsor · 2011-06-01
COMPLETEDSafety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid ArthritisNCT00867516 · lead sponsor · 2008-10-01
COMPLETEDSafety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and CachexiaNCT00866970 · lead sponsor · 2008-09-01
COMPLETEDA Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk LymphomaNCT03593187 · collaborator · 2019-01-15
COMPLETEDAdministration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart TransplantationNCT03341156 · collaborator · 2018-07-11
TERMINATEDEffects of Pulmonary Rehabilitation on Skeletal Muscle in COPD PatientsNCT02915614 · collaborator · 2017-03-02
UNKNOWNIg PRx in AECOPD: Pilot StudyNCT02690038 · collaborator · 2016-09-01
COMPLETEDAlpha-1 Carrier Genomics StudyNCT02810327 · collaborator · 2015-02-01
COMPLETEDA Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated MyelopathyNCT01561755 · collaborator · 2012-02-01
TERMINATEDTherapy to Elevate CD4 Counts in HIV-1 DiseaseNCT01370018 · collaborator · 2006-12-01
COMPLETEDSponsor roles
lead sponsor9
collaborator7
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.